Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 23884985)

1.

Glucocorticoid downregulates expression of IL-12 family cytokines in systemic lupus erythematosus patients.

Qiu F, Song L, Yang N, Li X.

Lupus. 2013 Sep;22(10):1011-6. doi: 10.1177/0961203313498799. Epub 2013 Jul 24.

PMID:
23884985
2.

Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus.

Qiu F, Song L, Ding F, Liu H, Shu Q, Yang N, Liu W, Li X.

Diagn Pathol. 2013 May 23;8:88. doi: 10.1186/1746-1596-8-88.

3.

Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus.

Song L, Qiu F, Fan Y, Ding F, Liu H, Shu Q, Liu W, Li X.

J Clin Immunol. 2013 Jan;33(1):111-7. doi: 10.1007/s10875-012-9791-z. Epub 2012 Sep 9.

PMID:
22961070
4.

Cytokine production, serum levels and disease activity in systemic lupus erythematosus.

Gröndal G, Gunnarsson I, Rönnelid J, Rogberg S, Klareskog L, Lundberg I.

Clin Exp Rheumatol. 2000 Sep-Oct;18(5):565-70.

PMID:
11072595
7.

Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus.

Robak E, Robak T, Wozniacka A, Zak-Prelich M, Sysa-Jedrzejowska A, Stepien H.

Eur Cytokine Netw. 2002 Jul-Sep;13(3):364-8.

PMID:
12231481
8.

Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus.

Mok MY, Huang FP, Ip WK, Lo Y, Wong FY, Chan EY, Lam KF, Xu D.

Rheumatology (Oxford). 2010 Mar;49(3):520-7. doi: 10.1093/rheumatology/kep402. Epub 2009 Dec 21.

9.

The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.

Guo H, Leung JC, Chan LY, Chan TM, Lai KN.

Rheumatology (Oxford). 2004 Mar;43(3):286-93. Epub 2003 Nov 17.

10.

Decreased interleukin 35 and CD4+EBI3+ T cells in patients with active systemic lupus erythematosus.

Ouyang H, Shi YB, Liu ZC, Wang Z, Feng S, Kong SM, Lu Y.

Am J Med Sci. 2014 Aug;348(2):156-61. doi: 10.1097/MAJ.0000000000000215.

PMID:
25054737
11.
12.

Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity.

Miret C, Molina R, Filella X, García-Carrasco M, Claver G, Ingelmo M, Ballesta A, Font J.

Tumour Biol. 2003 Aug-Sep;24(4):185-8.

PMID:
14654712
16.

Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.

Abou Ghanima AT, Elolemy GG, Ganeb SS, Abo Elazem AA, Abdelgawad ER.

Egypt J Immunol. 2012;19(2):25-33.

PMID:
23885404
17.
18.

IL-17 in cutaneous lupus erythematosus.

Tanasescu C, Balanescu E, Balanescu P, Olteanu R, Badea C, Grancea C, Vagu C, Bleotu C, Ardeleanu C, Georgescu A.

Eur J Intern Med. 2010 Jun;21(3):202-7. doi: 10.1016/j.ejim.2010.03.004. Epub 2010 Apr 8.

PMID:
20493423
20.

Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients.

Hermansen ML, Hummelshøj L, Lundsgaard D, Hornum L, Keller P, Fleckner J, Fox B, Poulsen LK, Jacobsen S.

Lupus. 2012 Sep;21(10):1098-104. doi: 10.1177/0961203312447668. Epub 2012 May 10.

PMID:
22577117
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk